MetaVia is trading at $1.70 (5.6% down) following a weak open and continued pressure from the prior session's decline.
- No company-specific catalysts have surfaced in available news to explain the downward move.
- The decline comes amid a broadly risk-off tone in technology and biotech names, which may be adding to the downside.